Honda Motor Company, Ltd. Common Stock (HMC)

Investing Cash Flow

-¥399.05B

Quarterly · Period ending: · JPY

HMC logo

HMC Investing Cash Flow

Latest reported-¥399.05B JPY
HMC Quarterly Cash from Investing · JPY (-¥179.03B → -¥399.05B)
High-resolution chart · PNG

HMC investing cash flow history

Quarterly · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.

Honda Motor Company, Ltd. Common Stock Investing Cash Flow — Quarterly (JPY)
Period endingInvesting Cash Flow (JPY)
-399,053,000,000
-316,485,000,000
-178,957,000,000
-146,643,000,000
-210,081,000,000
-305,192,000,000
-117,668,000,000
-326,506,000,000
-210,081,000,000
-305,192,000,000
-117,668,000,000
-326,506,000,000
-192,600,000,000
-93,369,000,000
-156,039,000,000
-150,367,000,000
-278,285,000,000
5,723,000,000
-155,069,000,000
-97,994,000,000
-128,716,000,000
-133,205,000,000
-360,431,000,000
-193,925,000,000
-109,320,000,000
-183,496,000,000
-60,409,000,000
-207,436,000,000
-168,140,000,000
-81,387,000,000
-119,282,000,000
-132,920,000,000
-243,966,000,000
-183,801,000,000
-122,653,000,000
-129,869,000,000
-178,790,000,000
-118,629,000,000
-191,340,000,000
-158,629,000,000
-182,020,000,000
-192,212,000,000
-254,342,000,000
-184,811,000,000
-243,712,000,000
140,956,000,000
-195,797,000,000
-180,976,000,000
-209,739,000,000
-364,255,000,000
-355,035,000,000
-491,283,000,000
-498,171,000,000
-287,935,000,000
-230,766,000,000
-292,284,000,000
-258,771,000,000
-215,486,000,000
-179,007,000,000
-98,735,000,000
-179,841,000,000
-116,059,000,000
-230,198,000,000
-208,924,000,000
-176,209,000,000
-131,454,000,000
-121,422,000,000
-137,318,000,000
-205,557,000,000
81,186,000,000
-177,144,035,000
-516,606,965,000
-520,799,000,000
-434,178,106,000
-352,325,237,000
-401,516,981,000
-493,503,282,000
-238,989,001,000
-107,662,312,000
-390,254,144,000
-394,411,357,000
-177,907,675,000
-66,871,208,000
-248,865,609,000
-179,025,009,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.